Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
暂无分享,去创建一个
Meilan K. Han | E. Hoffman | E. Bleecker | D. Couper | G. Criner | S. Rennard | W. Moore | N. Hansel | R. Barr | L. LaVange | L. Postow | W. Anderson | C. Galbán | J. Newell | J. Wells | M. Dransfield | L. Viviano | Lori A. Bateman | N. Alexis | A. Ceppe | C. Cooper | R. Paine | R. Kanner | J. Krishnan | S. Lazarus | P. Woodruff | L. Paulin | N. Putcha | A. Comellas | W. Labaki | R. Wise | R. Boucher | R. Kaner | S. Bhatt | Yvonne J. Huang | V. Ortega | I. Barjaktarevic | S. Christenson | D. Tashkin | C. Freeman | E. Kleerup | E. Oelsner | M. Drummond | A. Hastie | R. Burkes | Fernando J Martinez | R. Crystal | C. Doerschuk | M. Arjomandi | J. Curtis | C. Pirozzi | S. Raman | Cheryl Pirozzi | R. Bowler | S. Peters | D. Meyers | Chris E. Cooper | B. Drummond | W. O’Neal | Todd T. Brown | F. Martinez | M. Han | C. Cooper | Robert M. Burkes | Agathe S. Ceppe
[1] David A. Jolliffe,et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials , 2019, Thorax.
[2] J. Crapo,et al. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals , 2019, Annals of the American Thoracic Society.
[3] Benjamin M. Smith,et al. Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort , 2018, Annals of the American Thoracic Society.
[4] T. Niyonsenga,et al. Blood biomarkers as predictors of long‐term mortality in COPD , 2018, The clinical respiratory journal.
[5] David A. Jolliffe,et al. Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK , 2018, The Journal of Steroid Biochemistry and Molecular Biology.
[6] K. Kairaitis,et al. Body composition and micronutrient deficiencies in patients with an acute exacerbation of chronic obstructive pulmonary disease , 2017, Internal medicine journal.
[7] P. Lips,et al. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial , 2017, International journal of chronic obstructive pulmonary disease.
[8] Meilan K. Han,et al. Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort , 2017, The Lancet. Respiratory medicine.
[9] Chengdi Wang,et al. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis , 2016, International journal of chronic obstructive pulmonary disease.
[10] David Couper,et al. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. , 2016, American journal of respiratory and critical care medicine.
[11] Robert Paine,et al. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.
[12] W. Stanley,et al. Relation between Vitamin D Deficiency and Severity of Chronic Obstructive Pulmonary Disease-A Case Control Study. , 2016, Journal of clinical and diagnostic research : JCDR.
[13] S. Yadav,et al. Nutrition in chronic obstructive pulmonary disease: A review , 2015, Journal of translational internal medicine.
[14] S. A. Moosavi,et al. The Effects of Vitamin D Supplementation on Pulmonary Function of Chronic Obstructive Pulmonary Disease Patients, before and after Clinical Trial , 2015, Diseases.
[15] P. Bakke,et al. Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD , 2015, PloS one.
[16] David A. Jolliffe,et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.
[17] C. Bucca,et al. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients , 2014, Respiratory Research.
[18] Benjamin M. Smith,et al. Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2014, Thorax.
[19] T. Jørgensen,et al. Vitamin D Status and Chronic Obstructive Pulmonary Disease: A Prospective General Population Study , 2014, PloS one.
[20] Lisa M LaVange,et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.
[21] S. Bojesen,et al. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease , 2013, Thorax.
[22] C. Pedersen,et al. Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality – Results from a 10-Year Prospective Cohort Study , 2013, PloS one.
[23] P. Vokonas,et al. Vitamin D deficiency, smoking, and lung function in the Normative Aging Study. , 2012, American journal of respiratory and critical care medicine.
[24] Á. Pataki,et al. Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review , 2012, Expert review of respiratory medicine.
[25] P. Bakke,et al. Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D , 2012, PloS one.
[26] D. Riches,et al. Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 , 2012, The Journal of Immunology.
[27] M. Decramer,et al. High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease , 2012, Annals of Internal Medicine.
[28] L. Edwards,et al. Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.
[29] E. Ford,et al. Low concentrations of serum 25-hydroxyvitamin D associated with increased risk for chronic bronchitis among US adults , 2011, British Journal of Nutrition.
[30] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[31] Shelley Gorman,et al. Vitamin D deficiency causes deficits in lung function and alters lung structure. , 2011, American journal of respiratory and critical care medicine.
[32] T. Greulich,et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer , 2011, Respiratory research.
[33] I. Tsiligianni,et al. A systematic review of the role of vitamin insufficiencies and supplementation in COPD , 2010, Respiratory research.
[34] D. Niewoehner,et al. Vitamin D status and longitudinal lung function decline in the Lung Health Study , 2010, European Respiratory Journal.
[35] M. Decramer,et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene , 2009, Thorax.
[36] A. Gombart. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. , 2009, Future microbiology.
[37] M. Decramer,et al. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. , 2009, American journal of respiratory and critical care medicine.
[38] D. Bruce,et al. The paradoxical effects of vitamin D on type 1 mediated immunity. , 2008, Molecular aspects of medicine.
[39] R. Scragg,et al. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. , 2005, Chest.